Ophthalmic Disease Prevalence Models

Market Scope’s ophthalmic disease models offer extensive country-level prevalence data and five-year forecasts by age group for all countries with a population over a million.

These proprietary models take into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients’ diverse needs. Disease models are often used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.

Diseases Modeled

  • Angle-closure glaucoma
  • Open-angle glaucoma
  • Secondary glaucoma
  • Ocular hypertension
  • Early AMD
  • Late AMD
  • Wet AMD
  • Geographic Atrophy
  • Retinal Vein Occlusion
  • Diabetic Retinopathy
Dry Eye
Dry Eye
  • Preclinical dry eye
  • Dry eye
  • Those at risk for dry eye
  • Meibomian gland dysfunction with dry eye
  • Sjogren's with dry eye
  • Seven others
Refractive Error
Refractive Error
  • Myopia (by diopter)
  • Hyperopia (by diopter)
  • Presbyopia
  • Plano-presbyopes
  • Astigmatism
  • Keratoconus
  • Other Ectasias
  • Fuchs' Dystrophy
  • Other Dystrophies
  • Acquired & Infectious
  • Congenital
  • Other Keratitis

Use cases

  • Evaluation of target markets
  • Country-level market sizing and potential
  • Clinical trial planning
  • Product and company valuation
  • Allocation of resources

Available Models

2023 Retinal Disease Model, September, 2023
2023 Glaucoma Disease Model, March, 2023
US Refractive Quarterly Update: Q1 - 2023
2022 Dry Eye Disease Model, December, 2022
2022 Refractive Error Model, December, 2022

Learn More

Contact us using the button below to request more information about these models, request a sample, or schedule a time to discuss live with our team.

Join Market Scope Today

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more